Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFC Energy Regulatory News (AFC)

  • There is currently no data for AFC

Director Dealing

21 Oct 2011 07:00

RNS Number : 5858Q
AFC Energy Plc
21 October 2011
 



21 October 2011

 

 

AFC Energy PLC

("AFC Energy" or the "Company")

 

 

DIRECTOR DEALING

 

 

AFC Energy plc (LSE: AFC), a leading developer of alkaline fuel cells,announces that it received notification on 19 October 2011 that on 5 October 2011, Mitchell Field, a non-executive director of the Company, purchased 80,000 ordinary shares of 0.1 of one penny each in the capital of the Company ("Ordinary Shares") at a price of 27.5 pence per Ordinary Share. Following this purchase, Mitchell Field is interested in 2,197,027 Ordinary Shares representing approximately 1.2 per cent of the Company's total issued share capital and voting rights.

 

 

For further information, please contact:

 

AFC Energy plc

Tim Yeo, Chairman

Ian Balchin, Deputy Chairman

David Marson, Finance Director

+44 (0)1483 276726

 

Allenby Capital Limited

Nominated Adviser and Broker

Brian Stockbridge

Dan Robinson

+44 (0)20 3328 5656

Threadneedle Communications

John Coles

Fiona Conroy

+44 (0)20 7653 9850

 

 

 

About AFC Energy

AFC Energy is a leading developer of low-cost alkaline fuel cells. AFC Energy's technology is focused on large scale industrial applications and the objective of producing the lowest possible unit cost electricity. Please visit our website www.afcenergy.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMMBBTMBITTLB
Date   Source Headline
22nd Feb 20217:00 amRNSNotice of Results
9th Feb 20218:17 amRNSTotal Voting Rights
8th Feb 20217:00 amRNSAppointment of Chief Engineer and Product Officer
28th Jan 20217:00 amRNSHydrogen Fuel Cell System for Extreme E Unveiled
15th Jan 20215:09 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSStrategic Collaboration with Ricardo
12th Jan 202111:23 amRNSBlock listing application
16th Dec 20208:00 amRNSDirector share options
16th Dec 20207:00 amRNSStrategic partnership with ABB
2nd Dec 20201:04 pmRNSExercise of Options
30th Nov 20207:00 amRNSHead of Communications Appointment
25th Nov 20204:31 pmRNSExercise of Options
23rd Nov 20207:00 amRNSInvestment in new facility
20th Nov 20206:15 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSManufacturing Contract with BK Gulf
16th Nov 20204:10 pmRNSAppointment of Joint Broker
12th Nov 20207:00 amRNSCancellation of Convertible Loan Note Facility
3rd Nov 20207:00 amRNSYear End Operational Update
27th Oct 20202:56 pmRNSExtreme E highlights Fuel Cell EV Charging Tech
1st Oct 20202:51 pmRNSExercise of Options
1st Oct 20207:00 amRNSAFC to present AlkaMem® at Conference
1st Sep 20207:00 amRNSContract award
24th Jul 20207:00 amRNSInterim Results
22nd Jul 20208:00 amRNSHolding(s) in Company
22nd Jul 20208:00 amRNSHolding(s) in Company
17th Jul 202011:09 amRNSResult of General Meeting
15th Jul 20207:00 amRNSExtreme E Collaboration
8th Jul 20207:00 amRNSHolding(s) in Company
1st Jul 20207:00 amRNSResult of Fundraising
30th Jun 20204:41 pmRNSPrimaryBid.com Offer
30th Jun 20204:40 pmRNSFundraising
23rd Jun 20207:00 amRNSAlkaMem Update
19th Jun 20204:50 pmRNSExercise of Options
9th Jun 20207:00 amRNSHolding(s) in Company
8th Jun 20207:00 amRNSExercise of Options
5th Jun 202012:00 pmRNSExercise of Options
1st Jun 20207:00 amRNSACCIONA Collaboration
29th May 20204:36 pmRNSPrice Monitoring Extension
28th May 20207:00 amRNSHydroX-Cell(S) Update
20th May 20204:36 pmRNSPrice Monitoring Extension
19th May 20204:50 pmRNSHolding(s) in Company
19th May 20207:00 amRNSCOVID-19 Update
7th May 202012:07 pmRNSSecond Price Monitoring Extn
7th May 202012:02 pmRNSPrice Monitoring Extension
24th Apr 20209:38 amRNSResults of AGM and Q&A
23rd Apr 20203:44 pmRNSResult of AGM
22nd Apr 20207:00 amRNSGrant of EMI Options
16th Apr 20203:49 pmRNSAGM Update
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.